Literature DB >> 15857563

Assessing the quality of case-control association studies on the genetic basis of sepsis.

Sally H Vitali1, Adrienne G Randolph.   

Abstract

OBJECTIVE: To define methodological standards that would improve the quality and reproducibility of case-control genetic association studies in sepsis.
DESIGN: Summary of the published standards.
RESULTS: Twelve main criteria and measures for evaluation of those criteria were developed from a variety of reviews and editorials on the subject.
CONCLUSIONS: Case-control candidate gene association studies represent an important tool for understanding the role that genes play in the pathogenesis of sepsis. It is important, however, to understand the limitations of these studies and the need for replication.

Entities:  

Mesh:

Year:  2005        PMID: 15857563      PMCID: PMC3705716          DOI: 10.1097/01.PCC.0000161572.12676.91

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  24 in total

1.  Clinical epidemiological quality in molecular genetic research: the need for methodological standards.

Authors:  S T Bogardus; J Concato; A R Feinstein
Journal:  JAMA       Date:  1999-05-26       Impact factor: 56.272

2.  Minimal haplotype tagging.

Authors:  Paola Sebastiani; Ross Lazarus; Scott T Weiss; Louis M Kunkel; Isaac S Kohane; Marco F Ramoni
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-04       Impact factor: 11.205

3.  Jesting Pilate, genetic case-control association studies, and Heart.

Authors:  D Crossman; H Watkins
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

4.  Freely associating.

Authors: 
Journal:  Nat Genet       Date:  1999-05       Impact factor: 38.330

5.  Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease.

Authors:  S Nadel; M J Newport; R Booy; M Levin
Journal:  J Infect Dis       Date:  1996-10       Impact factor: 5.226

6.  Gm3;5,13,14 and type 2 diabetes mellitus: an association in American Indians with genetic admixture.

Authors:  W C Knowler; R C Williams; D J Pettitt; A G Steinberg
Journal:  Am J Hum Genet       Date:  1988-10       Impact factor: 11.025

7.  A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis.

Authors:  F Stüber; M Petersen; F Bokelmann; U Schade
Journal:  Crit Care Med       Date:  1996-03       Impact factor: 7.598

8.  Pneumococcal septic shock is associated with the interleukin-10-1082 gene promoter polymorphism.

Authors:  Bernhard M Schaaf; Florian Boehmke; Hamed Esnaashari; Ulrike Seitzer; Henning Kothe; Matthias Maass; Peter Zabel; Klaus Dalhoff
Journal:  Am J Respir Crit Care Med       Date:  2003-05-13       Impact factor: 21.405

9.  Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM).

Authors:  R S Spielman; R E McGinnis; W J Ewens
Journal:  Am J Hum Genet       Date:  1993-03       Impact factor: 11.025

Review 10.  Methodologic quality and genotyping reproducibility in studies of tumor necrosis factor -308 G-->A single nucleotide polymorphism and bacterial sepsis: implications for studies of complex traits.

Authors:  Dixie L Peters; Robert C Barber; Elizabeth M Flood; Harold R Garner; Grant E O'Keefe
Journal:  Crit Care Med       Date:  2003-06       Impact factor: 7.598

View more
  4 in total

1.  Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE Statement.

Authors:  Julian Little; Julian P T Higgins; John P A Ioannidis; David Moher; France Gagnon; Erik von Elm; Muin J Khoury; Barbara Cohen; George Davey-Smith; Jeremy Grimshaw; Paul Scheet; Marta Gwinn; Robin E Williamson; Guang Yong Zou; Kim Hutchings; Candice Y Johnson; Valerie Tait; Miriam Wiens; Jean Golding; Cornelia van Duijn; John McLaughlin; Andrew Paterson; George Wells; Isabel Fortier; Matthew Freedman; Maja Zecevic; Richard King; Claire Infante-Rivard; Alex Stewart; Nick Birkett
Journal:  Hum Genet       Date:  2009-02-01       Impact factor: 4.132

2.  STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement.

Authors:  Julian Little; Julian P T Higgins; John P A Ioannidis; David Moher; France Gagnon; Erik von Elm; Muin J Khoury; Barbara Cohen; George Davey-Smith; Jeremy Grimshaw; Paul Scheet; Marta Gwinn; Robin E Williamson; Guang Yong Zou; Kim Hutchings; Candice Y Johnson; Valerie Tait; Miriam Wiens; Jean Golding; Cornelia van Duijn; John McLaughlin; Andrew Paterson; George Wells; Isabel Fortier; Matthew Freedman; Maja Zecevic; Richard King; Claire Infante-Rivard; Alex Stewart; Nick Birkett
Journal:  PLoS Med       Date:  2009-02-03       Impact factor: 11.069

3.  STrengthening the REporting of Genetic Association studies (STREGA)--an extension of the STROBE statement.

Authors:  Julian Little; Julian P T Higgins; John P A Ioannidis; David Moher; France Gagnon; Erik von Elm; Muin J Khoury; Barbara Cohen; George Davey-Smith; Jeremy Grimshaw; Paul Scheet; Marta Gwinn; Robin E Williamson; Guang Yong Zou; Kim Hutchings; Candice Y Johnson; Valerie Tait; Miriam Wiens; Jean Golding; Cornelia van Duijn; John McLaughlin; Andrew Paterson; George Wells; Isabel Fortier; Matthew Freedman; Maja Zecevic; Richard King; Claire Infante-Rivard; Alex Stewart; Nick Birkett
Journal:  Eur J Clin Invest       Date:  2009-04       Impact factor: 4.686

Review 4.  Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE statement.

Authors:  Julian Little; Julian P T Higgins; John P A Ioannidis; David Moher; France Gagnon; Erik von Elm; Muin J Khoury; Barbara Cohen; George Davey-Smith; Jeremy Grimshaw; Paul Scheet; Marta Gwinn; Robin E Williamson; Guang Yong Zou; Kim Hutchings; Candice Y Johnson; Valerie Tait; Miriam Wiens; Jean Golding; Cornelia van Duijn; John McLaughlin; Andrew Paterson; George Wells; Isabel Fortier; Matthew Freedman; Maja Zecevic; Richard King; Claire Infante-Rivard; Alex Stewart; Nick Birkett
Journal:  Eur J Epidemiol       Date:  2009-02-03       Impact factor: 8.082

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.